Last updated on August 2019

A Study to Evaluate the Efficacy Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression


Brief description of study

The purpose of this study is to evaluate the efficacy of fixed dosed intranasal esketamine compared to intranasal placebo, as an add-on to an oral antidepressant in Japanese participants with treatment-resistant depression (TRD), in improving depressive symptoms.

Clinical Study Identifier: NCT02918318

Find a site near you

Start Over

Ongata Hospital

Hachioji-shi, Japan
  Connect »

Hirota Clinic

Kurume-shi, Japan
  Connect »

Arata Clinic

Nagasaki, Japan
  Connect »

Hikari Clinic

Okayama-shi, Japan
  Connect »

Ongata Hospital

Hachioji-Shi, Japan
  Connect »

Hikari Clinic

Okayama-Shi, Japan
  Connect »

Hirota Clinic

Kurume-Shi, Japan
  Connect »